Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization

Carregando...
Imagem de Miniatura
Citações na Scopus
33
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Citação
JOURNAL OF HOSPITAL INFECTION, v.100, n.1, p.83-91, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Bloodstream infections (BSI) are a major complication in the early phase of a haematopoietic stem cell transplant (HSCT). Aim: To describe the incidence and risk factors for BSI occurring in the pre-engraftment phase of HSCT, and its impact on mortality. Methods: Clinical variables of 232 HSCT patients were analysed retrospectively between 2014 and 2015. Univariate Cox regression analyses were performed to test the association between each covariate and the outcome. Covariates with P < 0.10 on univariate analysis were included in a multiple Cox regression analysis using a backward elimination method. Findings: The cumulative incidence of BSI was 25.4%, mainly caused by Gram-negative bacteria (GNB) (55.2%). Approximately 40.5% of the patients had gut colonization by multi-drug-resistant (MDR) bacteria (vancomycin-resistant enterococcus and carbapenem-resistant GNB). Among patients colonized by MDR GNB, 20% developed an overt BSI due to MDR bacteria with the same pattern of sensitivity. Of the 13 deaths related to infection, 10 were patients with BSI caused by MDR GNB. The independent risk factors for BSI were gut colonization by MDR bacteria including GNB (P < 0.001) and duration of neutropenia >10 days (P = 0.005), and those associated with BSI caused by MDR bacteria were age >62 years (P = 0.03), use of total parenteral nutrition (TPN) (P < 0.001) and previous gut colonization by MDR GNB (P = 0.002). Conclusions: Previous gut colonization by MDR was an independent risk factor for BSI, together with TPN and age, and had an impact on outcome. These findings suggest that gut decolonization may be a potential strategy to prevent BSI.
Palavras-chave
Multi-drug-resistant bacteria, Colonization, Haematopoietic stem cell transplant
Referências
  1. Bilinski J, 2016, BIOL BLOOD MARROW TR, V22, P1087, DOI 10.1016/j.bbmt.2016.02.009
  2. Blennow O, 2014, TRANSPL INFECT DIS, V16, P106, DOI 10.1111/tid.12175
  3. Bock AM, 2013, BIOL BLOOD MARROW TR, V19, P102, DOI 10.1016/j.bbmt.2012.08.016
  4. Centers for Disease Control and Prevention, 2018, MULT RES ORG CLOSTR
  5. Centers for Disease Control and Prevention, 2018, BLOOD STREAM INF EV
  6. Demiraslan H, 2017, AM J INFECT CONTROL, V45, P735, DOI 10.1016/j.ajic.2017.01.006
  7. Girmenia C, 2015, BONE MARROW TRANSPL, V50, P282, DOI 10.1038/bmt.2014.231
  8. Guthrie KA, 2010, BONE MARROW TRANSPL, V45, P675, DOI 10.1038/bmt.2009.216
  9. Levin ASS, 2011, GUIA UTILIZAACAO ANT, P48
  10. Lisboa LF, 2015, INT J INFECT DIS, V33, P171, DOI 10.1016/j.ijid.2015.02.001
  11. Pinana JL, 2014, ANN HEMATOL, V93, P299, DOI 10.1007/s00277-013-1872-4
  12. Macesic N, 2014, TRANSPL INFECT DIS, V16, P887, DOI 10.1111/tid.12298
  13. Matar MJ, 2006, AM J INFECT CONTROL, V34, P534, DOI 10.1016/j.ajic.2006.04.205
  14. Mendes ET, 2016, MEDICINE, V95, P5271
  15. Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024
  16. Nesher L, 2015, TRANSPL INFECT DIS, V17, P33, DOI 10.1111/tid.12323
  17. Ortega M, 2005, ANN HEMATOL, V84, P40, DOI 10.1007/s00277-004-0909-0
  18. Patriarca F, 2017, BIOL BLOOD MARROW TR, V23, P333, DOI 10.1016/j.bbmt.2016.11.005
  19. Poutsiaka DD, 2007, BONE MARROW TRANSPL, V40, P63, DOI 10.1038/sj.bmt.1705690
  20. Rolston KVI, 2007, BONE MARROW TRANSPL, V39, P567, DOI 10.1038/sj.bmt.1705639
  21. Wang L, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001931
  22. Wayne PA, 2015, M100S25 CLSI